| Year |
Citation |
Score |
| 2018 |
Gomez-Rubio P, Piñero J, Molina-Montes E, Gutiérrez-Sacristán A, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, et al. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. International Journal of Cancer. PMID 30229903 DOI: 10.1002/Ijc.31866 |
0.3 |
|
| 2017 |
Gomez-Rubio P, Rosato V, Marquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW, Farré A, Molero X, Löhr M, Ilzarbe L, Perea J, Greenhalf W, O'Rorke M, et al. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28383714 DOI: 10.1093/Annonc/Mdx167 |
0.331 |
|
| 2012 |
Gomez-Rubio P, Klimentidis YC, Cantu-Soto E, Meza-Montenegro MM, Billheimer D, Lu Z, Chen Z, Klimecki WT. Indigenous American ancestry is associated with arsenic methylation efficiency in an admixed population of northwest Mexico. Journal of Toxicology and Environmental Health. Part A. 75: 36-49. PMID 22047162 DOI: 10.1080/15287394.2011.615107 |
0.546 |
|
| 2011 |
Gomez-Rubio P, Roberge J, Arendell L, Harris RB, O'Rourke MK, Chen Z, Cantu-Soto E, Meza-Montenegro MM, Billheimer D, Lu Z, Klimecki WT. Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. Toxicology and Applied Pharmacology. 252: 176-82. PMID 21320519 DOI: 10.1016/J.Taap.2011.02.007 |
0.557 |
|
| 2010 |
Gomez-Rubio P, Meza-Montenegro MM, Cantu-Soto E, Klimecki WT. Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10. Journal of Applied Toxicology : Jat. 30: 260-70. PMID 20014157 DOI: 10.1002/Jat.1492 |
0.502 |
|
| Show low-probability matches. |